Evaluation of in vitro effects of some analgesic drugs on erythrocyte and recombinant carbonic anhydrase i and II

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 27, Issue 1, 2012, Pages 37-42

  Gökçe, Başak ^a   Gençer, Nahit ^a   Arslan, Oktay ^a   Turkoǧlu, Sumeyye Aydogan ^a   Alper, Meltem ^a   Köçkar, Feray ^a  

^a BALIKESIR UNIVERSITY   (Turkey)

Author keywords

Analgesic drugs; Carbonic anhydrase; IC 50; Inhibition

Indexed keywords

ANALGESIC AGENT; CARBONATE DEHYDRATASE; DEXAMETHASONE SODIUM PHOSPHATE; DEXKETOPROFEN; DICLOFENAC; DIPYRONE; RECOMBINANT CARBONATE DEHYDRATASE I; RECOMBINANT CARBONATE DEHYDRATASE II; RECOMBINANT PROTEIN; THIOCOLCHICOSIDE; TROMETAMOL; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ANALGESICS; CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; HUMANS; MOLECULAR STRUCTURE; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84855411559     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2011.574130     Document Type: Article

References (53)

1. Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-181. (Pubitemid 351194064)
2. Thiry A, Dogné JM, Masereel B, Supuran CT. Targeting tumorassociated carbonic anhydrase IX in cancer therapy. Trends Pharmacol Sci 2006;27:566-573. (Pubitemid 44574507)
3. McKiernan JM, Buttyan R, Bander NH, Stifelman MD, Katz AE, Chen MW et al. Expression of the tumor-associated gene MN: A potential biomarker for human renal cell carcinoma. Cancer Res 1997;57:2362-2365. (Pubitemid 27255890)
4. Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opin Ther Pat 2006;16:1627-1644.
5. Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146-189. (Pubitemid 36241096)
6. Smith KS, Ferry JG. Prokaryotic carbonic anhydrases. FEMS Microbiol Rev 2000;24:335-366.
7. Stams T, Christianson DW. The Carbonic Anhydrases-New Horizons (Eds. Chegwidden WR, Carter ND, Edwards YH), 2000, pp. 159-174.
8. Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199-229. (Pubitemid 39004275)
9. Nishimori I, Minakuchi T, Onishi S, Vullo D, Cecchi A, Scozzafava A et al. Carbonic anhydrase inhibitors: Cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. Bioorg Med Chem 2007;15:7229-7236. (Pubitemid 47539154)
10. Vullo D, Franchi M, Gallori E, Antel J, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. J Med Chem 2004;47:1272-1279. (Pubitemid 38229129)
11. Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. J Med Chem 2005;48:7860-7866. (Pubitemid 41698823)
12. Nishimori I, Minakuchi T, Onishi S, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. J Med Chem 2007;50:381-388. (Pubitemid 46147718)
13. Vullo D, Voipio J, Innocenti A, Rivera C, Ranki H, Scozzafava A et al. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett 2005;15:971-976. (Pubitemid 40458632)
14. Nishimori I. Acatalytic CAs: Carbonic anhydrase-related proteins. In: Supuran CT, Scozzafava A, Conway J. Eds. Carbonic Anhydrase-Its Inhibitors and Activators. CRC Press, Boca Raton (FL) USA 2004, pp. 25-43.
15. Vullo D, Franchi M, Gallori E, Pastorek J, Scozzafava A, Pastorekova S et al. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett 2003;13:1005-1009. (Pubitemid 36331787)
16. Vullo D, Innocenti A, Nishimori I, Pastorek J, Scozzafava A, Pastoreková S et al. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? Bioorg Med Chem Lett 2005;15:963-969. (Pubitemid 40458631)
17. Lehtonen J, Shen B, Vihinen M, Casini A, Scozzafava A, Supuran CT et al. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J Biol Chem 2004;279:2719-2727. (Pubitemid 38114261)
18. Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors: Inhibition of the transmembrane isozyme XIV with sulfonamides. Bioorg Med Chem Lett 2005;15:3828-3833. (Pubitemid 41095477)
19. Bekker A, Cooper PR, Frempong-Boadu A, Babu R, Errico T, Lebovits A. Evaluation of preoperative administration of the cyclooxygenase-2 inhibitor rofecoxib for the treatment of postoperative pain after lumbar disc surgery. Neurosurgery 2002;50:1053-7; discussion 1057.
20. Karst M, Kegel T, Lukas A, Lüdemann W, Hussein S, Piepenbrock S. Effect of celecoxib and dexamethasone on postoperative pain after lumbar disc surgery. Neurosurgery 2003;53:331-6; discussion 336.
21. Mauleón D, Artigas R, García ML, Carganico G. Preclinical and clinical development of dexketoprofen. Drugs 1996;52 Suppl 5:24-45; discussion 45.
22. Cabré F, Fernández MF, Calvo L, Ferrer X, García ML, Mauleón D. Analgesic, anti-inflammatory and antipyretic affects of S(+)-ketoprofen in vivo. J Clin Pharmacol 1998;38:3S-10S.
23. Gay C, Planas E, Donado M, Martinez JM, Artigas R, Torres F, MauleOn D, Carganico G. Analgesic affect of low doses of dexketoprofen in the dental pain model: A randomised, doubleblind, placebo-controlled study. Clin Drug Invest 1996;11:320-330.
24. Ezcurdia M, Cortejoso FJ, Lanzón R, Ugalde FJ, Herruzo A, Artigas R et al. Comparison of the efficacy and tolerability of dexketoprofen and ketoprofen in the treatment of primary dysmenorrhea. J Clin Pharmacol 1998;38:65S-73S. (Pubitemid 29047351)
25. Carr DB, Goudas LC. Acute pain. Lancet 1999;353:2051-2058. (Pubitemid 29271759)
26. Davis SS, Illum L, McVie JG, Tomlinson E. Microspheres and Drug Therapy. Amsterdam 1984:75-89.
27. Mollgøard K, Saunders NR. Complex tight junctions of epithelial and of endothelial cells in early foetal brain. J Neurocytol 1975;4:453-468.
28. Edwards JE, Meseguer F, Faura CC, Moore RA, McQuay HJ. Singledose dipyrone for acute postoperative pain. Cochrane Database Syst Rev 2001;CD003227.
29. Levy M, Zylber-Katz E, Rosenkranz B. Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinetic 1995;9:1-7.
30. Vlahov V, Badian M, Verho M, Bacracheva N. Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium. Eur J Clin Pharmacol 1990;38:61-65. (Pubitemid 20050813)
31. Lat L. Dypirone for treatment of post-operative pain. Anaesthesia 1973;28:43-47.
32. Stankov G, Schmieder G, Lechner FJ, Schinzel S. Observer blind multicentre study with dipyrone versus tramadol in postoperative pain. Eur J Pain 1995;16:56-63.
33. Garcia-Alonso F, Gonzales de Suso MJ, Lopes-Alvarez M, Palop R. Comparative study of the efficacy of dipyrone, diclofenac sodium and pethidine in acute renal colic. Eur J Clin Pharmmacol 1991;40:543-549.
34. Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS. Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs 1980;20:24-48. (Pubitemid 11245967)
35. Lötsch J, Kettenmann B, Renner B, Drover D, Brune K, Geisslinger G et al. Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: Relation to pharmacodynamics in an experimental pain model. Pharm Res 2000;17:77-84. (Pubitemid 30121103)
36. Small RE. Diclofenac sodium. Clin Pharm 1989;8:545-558. (Pubitemid 19215429)
37. Ho H, Liu CH, Lin HM, Sheu MT. The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation Int J Pharm 2003;251:67-78.
38. Weinling E, Sandouk P, Debray M, Scherrmann JM. Singleand repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers. Int J Clin Pharmacol Ther 1999;37:503-509. (Pubitemid 29467083)
39. Maren TH. A simplified micromethod for the determination of carbonic anhydrase and its inhibitors. J Pharm Exp Ther 1960;130:2629-2634.
40. Ozensoy O, Arslan O, Sinan SO. A new method for purification of carbonic anhydrase isozymes by affinity chromatography. Biochemistry Mosc 2004;69:216-219.
41. Kockar F, Maresca A, Aydin M, Isik S, Turkoglu S, Sinan S et al. Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors. Bioorg Med Chem 2010;18:5498-5503.
42. Böttcher K, Waheed A, Sly WS. Membrane-associated carbonic anhydrase from the crab gill: Purification, characterization, and comparison with mammalian CAs. Arch Biochem Biophys 1994;312:429-435. (Pubitemid 24259096)
43. Beydemir S, Gülçin I. Effects of melatonin on carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo. J Enzyme Inhib Med Chem 2004;19:193-197. (Pubitemid 38744994)
44. Zhenyan Y, Liping X, Seunghwan L, Rongqing ZA. Novel carbonic anhydrase from the mantle of the pearl oyster (Pinctada fucata). Comp Biochem Physiol B 2006;143:190-194.
45. Bülbül M, Hisar O, Beydemir S, Ciftçi M, Küfrevioglu OI. The in vitro and in vivo inhibitory effects of some sulfonamide derivatives on rainbow trout (Oncorhynchus mykiss) erythrocyte carbonic anhydrase activity. J Enzyme Inhib Med Chem 2003;18:371-375.
46. Supuran CT, Briganti F, Tilli S, Chegwidden WR, Scozzafava A. Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents? Bioorg Med Chem 2001;9:703-714. (Pubitemid 32208589)
47. Huang S, Xue Y, Sauer-Eriksson E, Chirica L, Lindskog S, Jonsson BH. Crystal structure of carbonic anhydrase from Neisseria gonorrhoeae and its complex with the inhibitor acetazolamide. J Mol Biol 1998;283:301-310. (Pubitemid 28466658)
48. Çelik I, Çamaş H, Arslan O, Küfrevioǧlu ÖI. The affects of some pesticides on human and bovine erythrocyte carbonic anhydrase enzyme activities in vitro. J Environ Sci Heal A 1996;31:2651-2657.
49. Vitale AM, Monserrat JM, Castilho P, Rodriguez EM. Inhibitory effects of cadmium on carbonic anhydrase activity and ionic regulation of the estuarine crab Chasmagnathus granulata (Decapoda, Grapsidae). Comp Biochem Physiol C, Pharmacol Toxicol Endocrinol 1999;122:121-129. (Pubitemid 29085531)
50. Gervais MR, Tufts BL. Characterization of carbonic anhydrase and anion exchange in the erythrocytes of bowfin (Amia calva), a primitive air-breathing fish. Comp Biochem Phys, 1999;23A:343-350. (Pubitemid 29414839)
51. Puscas I, Ifrim M, Maghiar T, Coltau M, Domuta G, Baican M et al. Indomethacin activates carbonic anhydrase and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide, by a direct mechanism of action. Int J Clin Pharmacol Ther 2001;39:265-270. (Pubitemid 32515065)
52. Leese MP, Leblond B, Smith A, Newman SP, Di Fiore A, De Simone G et al. 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: Synthesis, in vitro SAR, protein crystallography, and in vivo activity. J Med Chem 2006;49:7683-7696. (Pubitemid 46033660)
53. Innocenti A, Zimmerman SA, Scozzafava A, Ferry JG, Supuran CT. Carbonic anhydrase activators: Activation of the archaeal beta-class (Cab) and gamma-class (Cam) carbonic anhydrases with amino acids and amines. Bioorg Med Chem Lett 2008;18:6194-6198.